image
Healthcare - Biotechnology - NASDAQ - US
$ 0.803
-4.02 %
$ 3.45 M
Market Cap
-0.05
P/E
BALANCE SHEET
12.2 M ASSETS
121.91%
5.56 M LIABILITIES
25.03%
6.65 M EQUITY
531.64%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Revelation Biosciences, Inc.
image
Current Assets 12.1 M
Cash & Short-Term Investments 12 M
Receivables 0
Other Current Assets 156 K
Non-Current Assets 65.1 K
Long-Term Investments 0
PP&E 65.1 K
Other Non-Current Assets 0
Current Liabilities 5.56 M
Accounts Payable 1.36 M
Short-Term Debt 0
Other Current Liabilities 4.2 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019
ASSETS
Cash & Cash Equivalents 12.0 5.3 1.3 4.5 0
Short Term Investments 0 0 0 0.5 0
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 0.2 0.2 0.6 0.1 0
Total Current Assets 12.1 5.4 1.9 4.6 0
PP&E 65.1 K 90.1 K 0.1 0 0
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 73.5 0
Other Long Term Assets 0 0 0 0 22.7 K
Other Assets 0 0 0 (73.5) 0
Total Assets 12.2 5.5 2.0 4.6 22.7 K
LIABILITIES
Accounts Payable 1.4 0.6 0.6 0.9 0
Short Term Debt 0 0 16.8 K 0 0
Other Current Liabilities 4.2 3.9 1.5 0.3 26.3 K
Total Current Liabilities 5.6 4.5 2.1 1.2 26.3 K
Long Term Debt 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0 0 0 0 0
Total Liabilities 5.6 4.5 2.1 1.2 26.3 K
EQUITY
Common Stock 265 683 2.31 K 2.29 K 0
Retained Earnings (25.5) (25.3) (14.5) (2.5) 3.64 K
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0
Total Equity 6.6 1.1 99.5 K 3.4 3.64 K
Total Liabilities and Equity 12.2 5.5 2.0 4.6 22.7 K
SHARES OUTSTANDING
Common Shares Outstanding 0.2 0.5 0.4 8.66 K 8.66 K